Richard Eisenstadt

Richard Eisenstadt

Plus aucun poste en cours
68 ans
Health Technology
Consumer Services
Commercial Services

Profil

Richard I.
Eisenstadt
's former job positions include Director-Strategic Planning & Development at Nimbus CD International, Inc., Finance Director at Cogent Neuroscience, Inc., Chief Financial Officer & Director at Neostx, Inc., Chief Financial Officer, Secretary & VP at OCERA Therapeutics LLC from 2003 to 2012, Chief Financial Officer & Secretary at Neos Therapeutics, Inc. from 2014 to 2021, Chief Financial Officer at ArborGen, Inc. in 2013, Chief Financial Officer & Vice President-Finance at Tranzyme, Inc. from 2003 to 2012, Chief Financial Officer & Vice President-Finance at Tranzyme Pharma, Inc. (Canada) from 2003 to 2012, Chief Financial Officer, Secretary & Treasurer at Aytu Biopharma, Inc. in 2021, and Chief Financial & Accounting Officer, Secretary at Altimmune, Inc. from 2021 to 2024.
Education: Mr. Eisenstadt holds an MBA from James Madison University and an undergraduate degree from The University of North Carolina at Charlotte.

Anciens postes connus de Richard Eisenstadt

SociétésPosteFin
Directeur Financier/CFO 27/06/2024
ALTIMMUNE, INC. Directeur Financier/CFO 27/06/2024
AYTU BIOPHARMA, INC. Directeur Financier/CFO 30/12/2021
NEOS THERAPEUTICS, INC. Directeur Financier/CFO 19/03/2021
Directeur Financier/CFO 01/05/2014
Voir l'expérience en détail de Richard Eisenstadt

Formation de Richard Eisenstadt

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

29

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Consumer Services

Commercial Services

Health Technology

Consumer Services

Health Technology

Non-Energy Minerals

Health Technology

Tranzyme Pharma, Inc. (Canada)

Consumer Services

Cogent Neuroscience, Inc.

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Richard Eisenstadt
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇